Novel cyclopentenone derivatives produced by a rare actinobacterial strain Actinoalloteichus nanshanensis sp. nov. NEAU 119

Natural Product Research

Volumn 27, Issue 20, 2013, Pages 1863-1869

  Wang, Xiang Jing ^a   Zhang, Ji ^a   Wang, Ji Dong ^b   Qian, Ping Ting ^a,b   Liu, Chong Xi ^a   Xiang, Wen Sheng ^a  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

^b Zhejiang Hisun Pharmaceutical Co Ltd   (China)

Author keywords

Actinoalloteichus nanshanensis sp nov NEAU 119; cyclopentenone; cytotoxicity

Indexed keywords

2H 3,4,4A,5A,7,8 HEXHYDRO 4 HYDROXY PYRANO[2,3 B] CYCLOPENTA[D]PYRAN 9(6H) ONE); 2H 3,5A,7,8 HEXHYDRO PYRANO[2,3 B]CYCLOPENTA[D]PYRAN 9(6H) ONE); CYCLOPENTENONE DERIVATIVE; DOXORUBICIN; NATURAL PRODUCT; UNCLASSIFIED DRUG;

ACTINOALLOTEICHUS NANSHANENSIS; ACTINOBACTERIA; ARTICLE; BACTERIAL STRAIN; BIOASSAY; CARBON NUCLEAR MAGNETIC RESONANCE; CELL VIABILITY; CYTOTOXICITY; DRUG ISOLATION; HUMAN; HUMAN CELL; IC 50; KIDNEY CARCINOMA; LEUKEMIA CELL; NUCLEAR OVERHAUSER EFFECT; NUCLEOTIDE SEQUENCE; STEREOCHEMISTRY;

ACTINOALLOTEICHUS; ACTINOBACTERIA; ACTINOBACTERIA (CLASS);

ACTINOMYCETALES; ANTI-INFECTIVE AGENTS; CANDIDA ALBICANS; CELL LINE, TUMOR; CYCLOPENTANES; HUMANS; MOLECULAR STRUCTURE; RHIZOCTONIA; SPECIES SPECIFICITY; SPECTRUM ANALYSIS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84887613557     PISSN: 14786419     EISSN: 14786427     Source Type: Journal    
DOI: 10.1080/14786419.2013.771349     Document Type: Article

References (13)

1. Berdy J. 2005. Bioactive microbial metabolites. J Antibiot. 58:1-26. doi: 10. 1038/ja. 2005. 1.
2. Demain AL, Sanchez S. 2009. Microbial drug discovery: 80 years of progress. J Antibiot. 58:5-16. doi: 10. 1038/ ja. 2008. 16.
3. Hayakawa H, Nonomura H. 1987. Humic acid-vitamin agar, a new medium for the selective isolation of soil actinomycetes. J Ferment Technol. 65:501-509. doi: 10. 1016/0385-6380(87)90108-7.
4. Matteo C. 2006. Cyclopentenone: a special moiety for anticancer drug design. Anticancer Drugs. 17:1017-1022. doi: 10. 1097/01. cad. 0000231471. 54288. 00.
5. Ogi T, Margiastuti P, Teruya T, Taira J, Suenaga K, Ueda K. 2009. Isolation of C11 cyclopentenones from two didemnid species, Lissoclinum sp. and Diplosoma sp. Mar Drugs. 7:816-832. doi:10. 3390/md7040816.
6. Qin S, Li J, Chen H-H, Zhao G-Z, Zhu W-Y, Jiang C-L, Xu L-H, Li W-J. 2009. Isolation, diversity, and antimicrobial activity of rare actinobacteria from medicinal plants of tropical rain forests in Xishuangbanna, China. Appl Environ Microbiol. 75:6176-6186. doi: 10. 1128/AEM. 01034-09.
7. Rob T, Ogi T, Maarisit W, Taira J, Ueda K. 2011. Isolation of C11 compounds and a cyclopropane fatty acid from an Okinawan ascidian, Diplosoma sp. Molecules. 16:9972-9982. doi:10. 3390/molecules16129972.
8. Shi H, Yu S, Liu D, van Ofwegen L, Proksch P, Lin W. 2012. Sinularones A-I, new cyclopentenone and butenolide derivatives from a marine soft coral Sinularia sp. and their antifouling activity. Mar Drugs. 10:1331-1344. doi: 10. 3390/md10061331.
9. Takagi M, Shin-ya K. 2011. New species of actinomycetes do not always produce new compounds with high frequency. J Antibiot. 64:699-701. doi:10. 1038/ja. 2011. 66.
10. van Wagoner RM, Drummond AK, Wright JLC. 2007. Biogenetic diversity of cyanobacterial metabolites. Adv Appl Microbiol. 61:89-217. doi: 10. 1016/S0065-2164(06)61004-6.
11. Wang X-J, Gong D-L, Wang J-D, Zhang J, Liu C-X, Xiang W-S. 2011. A new quinoline derivative with cytotoxic activity from Streptomyces sp. neau50. Bioorg Med Chem Lett. 21:2313-2315. doi: 10. 1016/j. bmcl. 2011. 02. 095.
12. Xiang W-S, Liu C-X, Wang X-J, Du J, Xi L-J, Huang Y. 2011. Actinoalloteichus nanshanensis sp. nov., isolated from the rhizosphere of a fig tree (Ficus religiosa). Int J Syst Evol Microbiol. 61:1165-1169. doi 10. 1099/ijs. 0. 023283-0.
13. Zhang J, Wang X-J, Yan Y-J, Jiang L, Wang J-D, Li B-J, Xiang W-S. 2010. Isolation and identification of 5-hydroxyl-5-methy-2-hexenoic acid from Actinoplanes sp. HBDN08 with antifungal activity. Bioresour Technol. 101:8383-8388. doi: 10. 1016/j. biortech. 2010. 06. 052.